A. Doran Bostwick

ORCID: 0000-0003-4939-447X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pneumonia and Respiratory Infections
  • Nosocomial Infections in ICU
  • Antibiotic Use and Resistance
  • Healthcare Decision-Making and Restraints
  • Pulmonary Hypertension Research and Treatments
  • Emergency and Acute Care Studies
  • Liver Disease and Transplantation
  • T-cell and B-cell Immunology
  • Vascular Anomalies and Treatments
  • Immune Cell Function and Interaction
  • Palliative Care and End-of-Life Issues
  • Infections and bacterial resistance
  • Wound Healing and Treatments
  • Machine Learning in Healthcare
  • Patient Satisfaction in Healthcare
  • Healthcare Systems and Technology
  • Migration, Health and Trauma
  • Pharmaceutical Practices and Patient Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Trauma Management and Diagnosis
  • Interprofessional Education and Collaboration
  • Cancer Immunotherapy and Biomarkers
  • Ultrasound and Hyperthermia Applications
  • Child and Adolescent Health
  • Meta-analysis and systematic reviews

University of New Mexico
2021-2025

University of Utah
2018-2019

Pulmonary and Critical Care Associates
2019

Golisano Children's Hospital of Southwest Florida
2018

Duke Medical Center
2015

While blockade of the cytotoxic T-lymphocyte antigen-4 (CTLA-4) T cell regulatory receptor has become a commonly utilized strategy in management advanced melanoma, many questions remain regarding use this agent patient populations with autoimmune disease. We present case involving treatment stage IV melanoma and ulcerative colitis (UC) anti-CTLA-4 antibody immunotherapy. Upon initial treatment, developed grade III requiring tumor necrosis factor-alpha (TNF-α) blocking therapy, however...

10.1186/s40425-015-0064-2 article EN cc-by-nc-nd Journal for ImmunoTherapy of Cancer 2015-05-13

Rationale: The 2016 guidelines for hospital-acquired pneumonia (HAP) suggest applying a universal antibiogram resistance threshold in addition to patient criteria determine empiric coverage. impact of these recommendations is unknown.Objectives:1) Describe national antibiotic use and microbiology patterns HAP among patients with noninfectious admissions, 2) measure the predictive performance risk factors, 3) estimate change practice guideline implementation.Methods: We conducted...

10.1513/annalsats.201902-162oc article EN Annals of the American Thoracic Society 2019-08-06

Kerstersia spp. are an unusual cause of human infections. We report the first known case bacteremia and sepsis due to gyiorum, in a patient with chronic lower-extremity ulcers, we review literature on this uncommon pathogen.

10.1128/jcm.03625-14 article EN Journal of Clinical Microbiology 2015-03-26

10.21693/1933-088x-20.2.40 article EN Advances in Pulmonary Hypertension 2021-04-01

Medical research publications on sepsis have increased at an exponential rate, whereas our capacity to absorb and understand them has remained limited. We used topic modeling, a method that allows machines distill large amounts of information into its elemental themes, help us infer the discourse led present model/understanding sepsis. Using this model augment understanding sepsis, evolving, networked complex disease, we aimed recognize connections could be further explored aid in knowledge...

10.1093/ofid/ofy210.1804 article EN cc-by-nc-nd Open Forum Infectious Diseases 2018-11-01

Purpose: The purpose of this abstract is reducing delays in dispatch, deployment the team and better utilization services. use effective tools workflows to facilitate seamless dispatch eliminate goal all pediatric transport teams. As volume increases, so do missed transports for both Neonatal Pediatric Teams. secondary effect increased can compromise timely required …

10.1542/peds.141.1_meetingabstract.730 article EN 2018-01-01
Coming Soon ...